Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure
Marques, FZ, Prestes, PR, Byars, SG, Ritchie, SC, Wurtz, P, Patel, SK, Booth, SA, Rana, I, Minoda, Y, Berzins, SP, Curl, CL, Bell, JR, Wai, B, Srivastava, PM, Kangas, AJ, Soininen, P, Ruohonen, S, Kahonen, M, Lehtimaki, T, Raitoharju, E, Havulinna, A, Perola, M, Raitakari, O, Salomaa, V, Ala-Korpela, M, Kettunen, J, Mcglynn, Maree, Kelly, J, Wlodek, ME, Lewandowski, Paul, Delbridge, LM, Burrell, LM, Inouye, M, Harrap, SB and Charchar, FJ 2017, Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure, Journal of the American Heart Association, vol. 6, no. 6, pp. 1-57, doi: 10.1161/JAHA.117.005971.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.